| TOBRAMYCIN | None | ||
| 28MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| TOBI Podhaler is an aminoglycoside antibacterial indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa. | |||
|
Yes
| |||
| TOBI PODHALER | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||
| ************** ********* **** ******* ********** ****** | ************** ********* **** ******* ******** ********* ***** | ************-***** ******* *** **** ******** | ****** ***** ***-***** ******** ************** ************ *** **** ******** *** ******* ** *** | *******, ************ *** ******* *** *** ********* ******** ** *********** *********** | ********* ******** ** *************** | ********* ******** ** ************** | ********* ******** ** ************** | ************** ********* **** ******** ********* | ************** ********* **** *** ***** ****** | *************** ********* **** *** ***** ****** | ************** ********* **** ******* ******** ********* ***** | ******* ** ********* ** ************* ********** | ************** ********* **** *** ***** ****** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|